)
)
From Rare to Common: Insights Into Human Diseases From Proteogenomic Studies
Application of different omic technologies is now feasible at population scale. This talk will present examples of how the integration of different omics in large patient and population studies can help to predict disease risk, understand mechanisms, and reveal shared connections between rare and common diseases. Studies include different metabolomic and proteomic technologies and an investigation how these can be combined and how their complementarity can be employed for synergistic insights into human health.
